Cargando…

Surveillance and Treatment of Non-Muscle-Invasive Bladder Cancer in the USA

Seventy percent of newly diagnosed bladder cancers are classified as non-muscle-invasive bladder cancer (NMIBC) and are often associated with high rates of recurrence that require lifelong surveillance. Currently available treatment options for NMIBC are associated with toxicities that limit their u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barocas, Daniel A., Globe, Denise R., Colayco, Danielle C., Onyenwenyi, Ahunna, Bruno, Amanda S., Bramley, Thomas J., Spear, Rachel J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3357503/ https://www.ncbi.nlm.nih.gov/pubmed/22645607 http://dx.doi.org/10.1155/2012/421709

Ejemplares similares

Impact of urinary incontinence on health-related quality of life, daily activities, and healthcare resource utilization in patients with neurogenic detrusor overactivity
por: Tang, Derek H, et al.
Publicado: (2014)

Active surveillance for non-muscle invasive bladder cancer
por: Marcq, Gautier, et al.
Publicado: (2019)

Health claims database study of cyclosporine ophthalmic emulsion treatment patterns in dry eye patients
por: Stonecipher, Karl G, et al.
Publicado: (2013)

Cost-Effectiveness Analysis of OnabotulinumtoxinA (BOTOX(®)) for the Management of Urinary Incontinence in Adults with Neurogenic Detrusor Overactivity: A UK Perspective
por: Hamid, Rizwan, et al.
Publicado: (2014)

Cost‐effectiveness of surveillance schedules in older adults with non‐muscle‐invasive bladder cancer
por: Heijnsdijk, Eveline A.M., et al.
Publicado: (2018)

An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer
por: Soria, Francesco, et al.
Publicado: (2018)

Comparing CxBladder to Urine Cytology as Adjunct to Cystoscopy in Surveillance of Non-muscle Invasive Bladder Cancer—A Pilot Study
por: Chai, C. A., et al.
Publicado: (2021)

Surveillance of Low-Grade Non-Muscle Invasive Bladder Tumors Using Uromonitor: SOLUSION Trial
por: Azawi, Nessn, et al.
Publicado: (2023)

Understanding risk and refining surveillance following tumor resection for low grade non-muscle invasive bladder cancer
por: Peyton, Charles C., et al.
Publicado: (2018)

Current status of genetic urinary biomarkers for surveillance of non-muscle invasive bladder cancer: a systematic review
por: Lozano, F., et al.
Publicado: (2020)

Predictors of Outcome of Non–Muscle-Invasive and Muscle-Invasive Bladder Cancer
por: Youssef, Ramy F., et al.
Publicado: (2011)

Quality of life in patients undergoing surveillance for non-muscle invasive bladder cancer—a systematic review
por: Nayak, Arvind, et al.
Publicado: (2021)

Treatment and surveillance for non-muscle-invasive bladder cancer: a clinical practice guideline (2021 edition)
por: Jin, Ying-Hui, et al.
Publicado: (2022)

Is Regular Radiographic Upper Urinary Tract Imaging for Surveillance of Non-Muscle Invasive Bladder Cancer Justified?
por: Bieri, Uwe, et al.
Publicado: (2022)

Collagen stiffness promoted non-muscle-invasive bladder cancer progression to muscle-invasive bladder cancer
por: Zhu, Huier, et al.
Publicado: (2019)

Clinical Validation of a Urine Test (Uromonitor-V2(®)) for the Surveillance of Non-Muscle-Invasive Bladder Cancer Patients
por: Sieverink, Caroline A., et al.
Publicado: (2020)

Non-muscle invasive bladder cancer risk stratification
por: Isharwal, Sumit, et al.
Publicado: (2015)

Intravesical chemotherapy in non-muscle-invasive bladder cancer
por: Porten, Sima P., et al.
Publicado: (2015)

Molecular Landscape of Non-Muscle Invasive Bladder Cancer
por: Messing, Edward M.
Publicado: (2018)

Prediction tools in non-muscle invasive bladder cancer
por: Zamboni, Stefania, et al.
Publicado: (2019)

Histological variants in non-muscle invasive bladder cancer
por: Baumeister, Philipp, et al.
Publicado: (2019)

The present and future of non-muscle invasive bladder cancer
por: Moschini, Marco, et al.
Publicado: (2019)

Stepwise Application of Urine Markers to Detect Tumor Recurrence in Patients Undergoing Surveillance for Non-Muscle-Invasive Bladder Cancer
por: Todenhöfer, Tilman, et al.
Publicado: (2014)

The Role of Fluorescence In Situ Hybridization in the Surveillance of Non-Muscle Invasive Bladder Cancer: An Updated Systematic Review and Meta-Analysis
por: Zheng, Weitao, et al.
Publicado: (2022)

Follow-up in non-muscle invasive bladder cancer: facts and future
por: Witjes, J. Alfred
Publicado: (2020)

Bladder Preservation for Muscle Invasive Bladder Cancer
por: Mirza, Arafat, et al.
Publicado: (2016)

Genomic characterization of high-risk non-muscle invasive bladder cancer
por: Meeks, Joshua J., et al.
Publicado: (2016)

Active surveillance for nonmuscle invasive bladder cancer
por: Miyake, Makito, et al.
Publicado: (2016)

Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA — update 2018
por: Lotan, Yair, et al.
Publicado: (2019)

A novel signature constructed by differential genes of muscle-invasive and non-muscle-invasive bladder cancer for the prediction of prognosis in bladder cancer
por: Wang, Weizhuo, et al.
Publicado: (2023)

Surveillance of non-muscle invasive bladder cancer using fluorescence in situ hybridization: Protocol for a systematic review and meta-analysis
por: Lin, Tianhai, et al.
Publicado: (2019)

The reorganization in the post-COVID recovery period requires a rationalization of old schedules of surveillance of non-muscle invasive bladder cancer
Publicado: (2021)

Impact of an optimized surveillance protocol based on the European Association of Urology substratification on surveillance costs in patients with primary high-risk non-muscle-invasive bladder cancer
por: Fujita, Naoki, et al.
Publicado: (2023)

Metabolomics of Non-muscle Invasive Bladder Cancer: Biomarkers for Early Detection of Bladder Cancer
por: Cheng, Xiangming, et al.
Publicado: (2018)

Are we following the guidelines on non-muscle invasive bladder cancer?
por: Reis, Leonardo Oliveira, et al.
Publicado: (2016)

Guideline-based management of non-muscle invasive bladder cancer
por: Gregg, Justin R., et al.
Publicado: (2015)

Role of Re-Resection in Non–Muscle-Invasive Bladder Cancer
por: Herr, Harry W.
Publicado: (2011)

Review on gender differences in non-muscle invasive bladder cancer
por: Bilski, Konrad, et al.
Publicado: (2019)

Non-muscle invasive bladder cancer biomarkers beyond morphology
por: De Carlo, Camilla, et al.
Publicado: (2022)

Detection of functional antigen-specific T cells from urine of non-muscle invasive bladder cancer patients
por: Pieraerts, Claire, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_o7ttu84ld3jretol4d59mp97kc